Literature DB >> 17660102

US outpatient office visits for bronchiolitis, 1993-2004.

Jonathan M Mansbach1, Andrea J Pelletier, Carlos A Camargo.   

Abstract

OBJECTIVE: To describe the clinical epidemiology of US outpatient visits for children younger than 2 years with bronchiolitis.
METHODS: Data were obtained from the 1993-2004 National Ambulatory Medical Care Survey. Visits had ICD-9 code 466 and were restricted to patients younger than 2 years. National estimates were obtained by using assigned patient visit weights and reported with 95% confidence intervals (95% CIs) calculated by the relative standard error of the estimate; analysis included the chi2 test.
RESULTS: From 1993 to 2004, bronchiolitis accounted for approximately 198 outpatient visits representing 8.75 million visits for children younger than 2 years. Among this same age group, the overall rate was 103 (95% CI, 83, 124) per 1000 US children and 17 (95% CI, 13, 20) per 1000 visits. When we compared bronchiolitis visits to all nonbronchiolitis visits, we found that those with bronchiolitis were less likely to be from the Northeast (12% vs 22%; P < .05) and more likely to be admitted to the hospital (2% vs 0.4%; P < .05). Fifty-two percent were prescribed albuterol; diagnostic tests were uncommon.
CONCLUSIONS: The annual number of outpatient office visits for bronchiolitis among children younger than 2 years has remained stable over the last decade but has averaged almost 750,000 visits per year. More than half of primary care providers are prescribing medications to children with bronchiolitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17660102     DOI: 10.1016/j.ambp.2007.03.006

Source DB:  PubMed          Journal:  Ambul Pediatr        ISSN: 1530-1567


  10 in total

1.  Testing for meningitis in children with bronchiolitis.

Authors:  Michael Stefanski; Ronald Williams; George McSherry; Joseph Geskey
Journal:  Perm J       Date:  2014

2.  Increasing burden and risk factors for bronchiolitis-related medical visits in infants enrolled in a state health care insurance plan.

Authors:  Kecia N Carroll; Tebeb Gebretsadik; Marie R Griffin; Pingsheng Wu; William D Dupont; Edward F Mitchel; Rachel Enriquez; Tina V Hartert
Journal:  Pediatrics       Date:  2008-07       Impact factor: 7.124

Review 3.  Glucocorticoids for acute viral bronchiolitis in infants and young children.

Authors:  Ricardo M Fernandes; Liza M Bialy; Ben Vandermeer; Lisa Tjosvold; Amy C Plint; Hema Patel; David W Johnson; Terry P Klassen; Lisa Hartling
Journal:  Cochrane Database Syst Rev       Date:  2013-06-04

Review 4.  Recent evidence on the management of bronchiolitis.

Authors:  Alan R Schroeder; Jonathan M Mansbach
Journal:  Curr Opin Pediatr       Date:  2014-06       Impact factor: 2.856

5.  Frequency, duration and predictors of bronchiolitis episodes of care among infants ≥32 weeks gestation in a large integrated healthcare system: a retrospective cohort study.

Authors:  Valerie J Flaherman; Arona I Ragins; Sherian Xu Li; Patricia Kipnis; Anthony Masaquel; Gabriel J Escobar
Journal:  BMC Health Serv Res       Date:  2012-06-08       Impact factor: 2.655

6.  Risk of urinary tract infection in infants and children with acute bronchiolitis.

Authors:  Mohamed A Hendaus; Ahmed H Alhammadi; Mohamed S Khalifa; Eshan Muneer; Prem Chandra
Journal:  Paediatr Child Health       Date:  2015 Jun-Jul       Impact factor: 2.253

7.  Which ICD-9-CM codes should be used for bronchiolitis research?

Authors:  Paul Walsh; Stephen J Rothenberg
Journal:  BMC Med Res Methodol       Date:  2018-11-22       Impact factor: 4.615

8.  A randomized controlled trial of a combination of antiviral and nonsteroidal anti-inflammatory treatment in a bovine model of respiratory syncytial virus infection.

Authors:  Paul Walsh; Maxim Lebedev; Heather McEligot; Victoria Mutua; Heejung Bang; Laurel J Gershwin
Journal:  PLoS One       Date:  2020-03-12       Impact factor: 3.240

9.  [Consensus conference on acute bronchiolitis (II): epidemiology of acute bronchiolitis. Review of the scientific evidence].

Authors:  C Ochoa Sangrador; J González de Dios
Journal:  An Pediatr (Barc)       Date:  2010-02-13       Impact factor: 1.500

10.  Analysis of lung transcriptome in calves infected with Bovine Respiratory Syncytial Virus and treated with antiviral and/or cyclooxygenase inhibitor.

Authors:  Maxim Lebedev; Heather A McEligot; Victoria N Mutua; Paul Walsh; Francisco R Carvallo Chaigneau; Laurel J Gershwin
Journal:  PLoS One       Date:  2021-02-18       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.